drugset / Trial / NCT02006108
Imaging Kidney Transplant Rejection Using Ferumoxytol-Enhanced Magnetic Resonance
NaSingle-groupOpen-labelDiagnostic
Summary
The goal of this study is to develop a non-invasive imaging test for in vivo detection of kidney transplant rejection. The hypotheses are that 1) Ferumoxytol-MRI can generate accurate estimates of tissue iron concentrations and tissue macrophages. 2) The signal given by a renal allograft on Ferumoxytol-MRI demonstrates significant differences between rejected and non-rejected transplants.
Timeline
- Start
- 2012-11-27
- Primary completion
- 2017-04-11
- Completion
- 2017-04-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferumoxytol | Diagnostic / imaging agent | 5 mg/kg | Intravenous |